YungShin Global Holding Corporation is a pharmaceutical group that operates across the drug supply chain, covering active pharmaceutical ingredients, research and development, manufacturing, and sales. The company's product portfolio includes human prescription drugs, over-the-counter medicines, veterinary pharmaceuticals, health supplements, and beauty care products. Key subsidiaries include YungShin Pharmaceutical, Yongri Chemical, and Yonghong Biotech. The group serves markets in Asia, including operations in China and Malaysia, and holds WHO GMP certifications. Founded in 1952, the company integrates global resources to expand its presence in high-potential health markets.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Drug Manufacturers - General Homepage yungshingroup.com
Sector Healthcare IR page —
Tags
pharmaceuticals, active pharmaceutical ingredients, veterinary drugs, health supplements, beauty care, drug manufacturing, pharmaceutical r&d, YungShin Pharmaceutical, Yongri Chemical, Yonghong Biotech, YungShin Li Tian-De Medical Foundation, YungShin Social Welfare Foundation, YungShin Songbaiyuan Elderly Care Center
Press page —

Metrics

Valuation  
Market cap NT$ 15.394B
Market cap (USD) $ 467.225M
P/E 16.19
PEG 9.91
P/BV 1.91
P/S 1.94
P/OCF 11.34
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 10.9%
ROI 10.8%
ROIC 11.8%
Profit margin 10.5%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 1.6%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 18.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 8.376B 8.032B 7.028B 7.312B 7.805B 8.085B 8.192B 7.514B 6.623B 6.191B 6.034B 5.827B 5.062B 4.703B 4.502B 4.143B
Net profit 880.815M 1.169B 827.304M 839.035M 736.622M 791.72M 748.601M 701.982M 514.056M 657.993M 893.254M 720.058M 618.969M 444.535M 554.13M 635.063M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 57 53.9 46.5 46 42.95 44.7 — — — — — — — — — —
Price performance 12m 0.06 0.16 0.01 0.07 -0.04 — — — — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

YungShin Global Holding Corporation (ticker 3705.TW), listed in Taiwan.

ETFs Holding YungShin Global Holding Corporation

ETF Weight in ETF Shares Market value As of
AVEE 0.02% 17,000 $ 30.369K Nov 16, 2026
DEXC 0.01% 12,000 $ 21.365K Nov 12, 2026
DFEV 0.01% 71,000 $ 126.411K Nov 12, 2026
DFSE 0.01% 17,000 $ 30.267K Nov 12, 2026
DFEM 0.01% 257,000 $ 457.571K Nov 12, 2026
DFAE 0.00% 129,000 $ 229.676K Nov 12, 2026
DFAX 0.00% 110,950 $ 197.539K Nov 12, 2026
AVEM 0.00% 155,000 $ 276.889K Nov 16, 2026
AVES 0.00% 30,000 $ 53.592K Nov 16, 2026
AVXC 0.00% 6,000 $ 10.718K Nov 16, 2026